Gross Profit - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Gross Profit

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Gross Profit Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors

Company Gross Profit CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Gross Profit
€1.7m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Gross Profit
€85.8m
CAGR 3-Years
27%
CAGR 5-Years
6%
CAGR 10-Years
16%
Nanobiotix SA
PAR:NANO
Gross Profit
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Innate Pharma SA
PAR:IPH
Gross Profit
€21.9m
CAGR 3-Years
-11%
CAGR 5-Years
-28%
CAGR 10-Years
N/A
Genfit SA
NASDAQ:GNFT
Gross Profit
€36m
CAGR 3-Years
85%
CAGR 5-Years
45%
CAGR 10-Years
23%
Eurobio Scientific SA
PAR:ALERS
Gross Profit
€61.2m
CAGR 3-Years
-18%
CAGR 5-Years
27%
CAGR 10-Years
16%

See Also

What is Maat Pharma SA's Gross Profit?
Gross Profit
1.7m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Gross Profit amounts to 1.7m EUR.

What is Maat Pharma SA's Gross Profit growth rate?
Gross Profit CAGR 1Y
52%

Over the last year, the Gross Profit growth was 52%.

Back to Top